Crossmark

Population pharmacokinetic characteristics of tacrolimus in Chinese lung transplant recipients and optimisation of dosing regimen during the early post-transplantation phase

Crossref DOI link: https://doi.org/10.1007/s00228-025-03920-9

Published Online: 2025-09-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Shouning

Lian, Qiaoyan

Luo, Huilong

Xie, Hui

Guan, Yanping

He, Jianxing

Wei, Li

Ju, Chunrong
Funding

Funding for this research was provided by:

the 2022 Pharmaceutical Research Fund of Guangdong Province Hospital Association (2022YXKY15)

the Foundation from The State Key Laboratory of Respiratory Disease (SKLRD-QN-201710)

the Foundation from Guangzhou Institute of Respiratory Health (2019 GIRHZ04)

ZHONGNANSHAN Medical Foundation of Guangdong Province (ZNSA-2020013)
License Information

Text and Data Mining valid from 2025-09-23

Version of Record valid from 2025-09-23
More Information

Article History

Received: 25 March 2025

Accepted: 29 August 2025

First Online: 23 September 2025

Declarations

:

: This study was approved by the Ethics Committees of the The First Affiliated Hospital of Guangzhou Medical University (ES-2023-K010). Informed consent was obtained from all participants included in the study.

: Patients signed informed consent regarding publishing their data.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below